Cargando…
Cross-Immunization Against Respiratory Coronaviruses May Protect Children From SARS-CoV2: More Than a Simple Hypothesis?
In January 2020, a new coronavirus was identified as responsible for a pandemic acute respiratory syndrome. The virus demonstrated a high infectious capability and not-neglectable mortality in humans. However, similarly to previous SARS and MERS, the new disease COVID-19 caused by SARS-CoV-2 seemed...
Autores principales: | Piccaluga, Pier Paolo, Malerba, Giovanni, Navari, Mohsen, Diani, Erica, Concia, Ercole, Gibellini, Davide |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7849449/ https://www.ncbi.nlm.nih.gov/pubmed/33537261 http://dx.doi.org/10.3389/fped.2020.595539 |
Ejemplares similares
-
COVID-19 Vaccine: Between Myth and Truth
por: Piccaluga, Pier Paolo, et al.
Publicado: (2022) -
CFTR Inhibitors Display In Vitro Antiviral Activity against SARS-CoV-2
por: Lagni, Anna, et al.
Publicado: (2023) -
Assessment of SARS-CoV-2 IgG and IgM antibody detection with a lateral flow immunoassay test
por: Diani, Erica, et al.
Publicado: (2021) -
Duplex real-time polymerase chain reaction assay for the detection of human KIPyV and WUPyV in nasopharyngeal aspirate pediatric samples
por: Ligozzi, Marco, et al.
Publicado: (2018) -
Interferon gamma inducible protein 16 (IFI16) expression is reduced in mantle cell lymphoma
por: Piccaluga, Pier Paolo, et al.
Publicado: (2019)